olmesartan has been researched along with ramipril in 8 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (ramipril) | Trials (ramipril) | Recent Studies (post-2010) (ramipril) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 2,151 | 606 | 509 |
| Protein | Taxonomy | olmesartan (IC50) | ramipril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.004 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.253 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kintscher, U | 1 |
| Fischer, JW; Fritzenkötter, C; Li, J; Sandmann, S; Spormann, J; Tiede, K; Unger, T | 1 |
| Achard, JM; Faure, S; Fournier, A; Javellaud, J; Oudart, N; Warnock, DG | 1 |
| Malacco, E; Mallion, JM; Omboni, S; Volpe, M; Zanchetti, A | 1 |
| Fabrizzi, P; Malacco, E; Mallion, JM; Omboni, S; Volpe, M | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| Malacco, E; Mallion, JM; Omboni, S; Volpe, M | 1 |
| Armario, P; Banegas, JR; de la Cruz, JJ; de la Sierra, A; Gorostidi, M; Oliveras, A; Ruilope, LM; Segura, J; Vinyoles, E | 1 |
1 review(s) available for olmesartan and ramipril
| Article | Year |
|---|---|
Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Ramipril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2014 |
2 trial(s) available for olmesartan and ramipril
| Article | Year |
|---|---|
Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Office Visits; Placebos; Ramipril; Tetrazoles | 2012 |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Practice Guidelines as Topic; Ramipril; Tetrazoles; Treatment Outcome | 2015 |
5 other study(ies) available for olmesartan and ramipril
| Article | Year |
|---|---|
[Olmesartan after experimental myocardial infarct compared with ramipril: organ protective effect].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotonic Agents; Diet, Atherogenic; Drug Evaluation, Preclinical; Imidazoles; Myocardial Infarction; Ramipril; Rats; Tetrazoles | 2005 |
Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Inflammation; Interleukin-1; Interleukin-6; Male; Myocardial Infarction; Placebos; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Gerbillinae; Imidazoles; Kaplan-Meier Estimate; Male; Memory Disorders; Neuroprotective Agents; Ramipril; Recombinant Proteins; Stroke; Tetrazoles | 2006 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Mineralocorticoid Receptor Antagonists; Ramipril; Tetrazoles | 2018 |